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Abstract
Introduction:  Several  studies  have  associated  congenital  sensorineural  hearing  loss  in  children
with prolongation  of  the  cardiac  parameter  QTc.  The  cause  of  this  association  is  unknown.  At
the same  time,  mutations  in  GJB2,  which  encodes  connexin  26,  are  the  most  common  cause  of
congenital  hearing  impairment.
Objective:  To  compare  electrocardiographic  parameters  (PR  interval,  QRS  complex,  and  QTc
interval)  in  patients  with  hearing  loss  who  were  tested  for  mutations  in  GJB2  and  GJB6  to
investigate  whether  these  mutations  affect  electrical  activity  of  the  heart.
Methods:  346  patients  (176  males,  170  females)  with  sensorineural  hearing  loss  of  30  dB  HL  or
more, aged  21.8  ±  19.9  years  (including  147  children  <14  years),  underwent  both  genetic  study
for GJB2  and  GJB6  mutations  and  electrocardiography.
Results:  Mutations  in  GJB2,  including  homozygotes  and  heterozygotes,  were  found  in  112  (32%)
patients. There  were  no  signiﬁcant  differences  in  ECG  parameters  between  groups  of  patients
with and  without  mutations  in  GJB2.  No  differences  were  observed  either  in  men  (mean  PR
with mutation:  155  ±  16.6  vs.  153.6  ±  30.1  without;  QRS:  99.9  ±  9.9  vs.  101.1  ±  15.4;  QTc:
414.9 ±  29.9  vs.  412.4  ±  25.7)  or  women  (mean  PR  with:  148.7  ±  21  vs.  143.8  ±  22.8  without;
QRS: 94.8  ±  7.6  vs.  92.9  ±  9.6;  QTc:  416.8  ±  20.6  vs.  424.9  ±  22.8).  In  similar  fashion,  we  did
we ﬁnd  any  signiﬁcant  differences  between  groups  of  children  with  and  without  GJB2  muta-
tions (mean  PR  with:  126.3  ±  19.6  vs.  127  ±  19.7  without;  QRS:  80.7  ±  9.5  vs.  79.4  ±  11.6;  QTc:
419.7 ±  23.5  vs.  419.8  ±  24.8).
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Conclusion:  No  association  was  found  between  the  presence  of  GJB2  mutations  encoding  con-
nexin 26  in  patients  with  hearing  loss  and  their  ECG  parameters  (PR,  QRS,  QTc).
© 2016  Published  by  Elsevier  Editora  Ltda.  on  behalf  of  Associação  Brasileira  de  Otorrino-
laringologia  e  Cirurgia  Cérvico-Facial.  This  is  an  open  access  article  under  the  CC  BY  license
(http://creativecommons.org/licenses/by/4.0/).
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Avaliac¸ão  dos  parâmetros  eletrocardiográﬁcos  em  pacientes  com  perda  auditiva
genotipada  para  mutac¸ões  do  gene  conexina  26  (GJB2)
Resumo
Introduc¸ão:  Vários  estudos  têm  associado  a  perda  auditiva  neurossensorial  congênita  em
crianc¸as ao  prolongamento  do  parâmetro  cardíaco  QTc.  A  causa  desta  associac¸ão  é  descon-
hecida. Ao  mesmo  tempo,  as  mutac¸ões  no  GJB2,  que  codiﬁca  a  conexina  26,  são  a  causa  mais
comum de  deﬁciência  auditiva  congênita.
Objetivo:  Comparar  parâmetros  eletrocardiográﬁcos  (intervalo  PR,  complexos  QRS  e  intervalo
QTc) em  pacientes  com  perda  auditiva  que  foram  testados  para  mutac¸ões  no  GJB2  e  GJB6  para
investigar se  estas  mutac¸ões  afetam  a  atividade  elétrica  do  corac¸ão.
Método: Ao  todo,  346  pacientes  (176  homens,  170  mulheres)  com  perda  auditiva  neurossensorial
de 30  dB  ou  mais,  com  média  de  idade  de  21,8  ±  19,9  anos  (incluindo  147  crianc¸as  <14  anos),
foram submetidos  a  estudo  genético  para  mutac¸ões  de  GJB2  e  GJB6  e  eletrocardiograma.
Resultados:  Mutac¸ões  no  GJB2,  incluindo  homozigóticos  e  heterozigóticos,  foram  encontradas
em 112  (32%)  pacientes.  Não  houve  diferenc¸as  signiﬁcativas  nos  parâmetros  de  ECG  entre  grupos
de pacientes  com  e  sem  mutac¸ões  no  GJB2.  Não  foram  observadas  diferenc¸as  em  homens  (PR
médio com  mutac¸ão:  155  ±  16,6  vs  153,6  ±  30,1  sem  mutac¸ão;  QRS:  99,9  ±  9,9  vs  101,1  ±
15,4; QTc:  414,9  ±  29,9  vs  412,4  ±  25,7)  nem  em  mulheres  (PR  médio  com:  148,7  ±  21  vs.  143,8
± 22,8,  sem;  QRS:  94,8  ±  7,6  vs  92,9  ±  9,6;  QTc:  416,8  ±  20,6  vs  424,9  ±  22,8).  Da  mesma
forma, encontramos  diferenc¸as  signiﬁcativas  entre  os  grupos  de  crianc¸as  com  e  sem  mutac¸ões
de GJB2  (PR  médio  com:  126,3  ±  19,6  vs  127  ±  19,7,  sem;  QRS:  80,7  ±  9,5  vs  79,4  ±  11,6;  QTc:
419,7 ±  23,5  vs.  419,8  ±  24,8).
Conclusão:  Não  foi  encontrada  associac¸ão  entre  a  presenc¸a  de  mutac¸ões  de  GJB2  que  codiﬁcam
conexina  26  em  pacientes  com  perda  auditiva  e  seus  parâmetros  de  ECG  (PR,  QRS,  QTc).
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  da  Associação  Brasileira  de  Otorrino-
laringologia  e  Cirurgia  Cérvico-Facial.  Este  é  um  artigo  Open  Access  sob  a  licença  de  CC  BY
(http://creativecommons.org/licenses/by/4.0/).
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skin,  and  other  defects.ntroduction
onnexins  are  integral  transmembrane  proteins  which  form
hannels  in  the  cell  membrane  called  connexons.  In  adjacent
ells,  connexons  form  tight  junctions  that  are  necessary  for
ransfer  of  electrical  signals  and  water-soluble  molecules.
onnexons  help  maintain  tissue  homeostasis  and  assist  in  the
anagement  and  regulation  of  a  cell’s  ionic  environment.1
Connexins  are  present  throughout  the  human  body.  Even
hough  cells  can  contain  a  number  of  different  connex-
ns,  each  plays  a  separate  role.  In  humans,  there  are  21
roteins  belonging  to  the  connexin  family,  and  each  is
ncoded  by  a  different  gene.2 Mutations  in  genes  encod-
ng  connexins  create  disturbances  in  their  structure  and
unction,  which  can  lead  to  hereditary  diseases  such  as
eafness,  cataracts,  skin  diseases,  and  neurodegenerative
onditions.3--6
In  the  cells  of  the  inner  ear,  connexin  26  and  connexin  30
re  involved  in  potassium  ion  transport  processes  necessary
or  hearing.  When  a  hair  cell  is  stimulated,  potassium  ions
n  the  endolymph  enter  the  cilia  and  body  of  the  cell,  caus-
ng  it  to  depolarize.  Due  to  gap-junction  connections,  ions
i
cre  in  turn  transported  by  supporting  cells  and  cells  in  stria
ascularis  to  endolymph.  Via  this  recirculation  of  potassium
ons,  a  highly  positive  (+80  mV)  endolymphatic  potential  is
enerated,  a  necessary  condition  for  hearing.  Disruption  of
his  mechanism  causes  potassium  ion  intoxication  and  tissue
amage.7
Both  the  GJB2  (MIM*121011)  gene  (encoding  connexin  26)
nd  the  GJB6  (MIM*604418)  gene  (encoding  connexin  30)  are
ocated  on  chromosome  13  (13q11--q12).  Mutations  of  the
JB2  gene  lead  to  disturbances  in  the  functioning  of  con-
exin  26,  causing  hearing  loss  (HL)  by  impairing  transfer
f  intracellular  potassium  ions  within  the  inner  ear.8 GJB2
utations  are  a  major  cause  of  autosomal  recessive  nonsyn-
romic  HL  in  many  populations.  Among  Europeans,  the  most
ommon  pathogenic  mutation  in  the  GJB2  gene  is  a  dele-
ion  of  guanine  at  position  35  (NM  004004.5:c.35delG).9,10 In
ost  cases  (70%),  HL  occurs  as  an  isolated  defect;  in  other
nstances  it  is  accompanied  by  heart,  craniofacial,  kidney,Several  studies  have  reported  an  association  of  congen-
tal  sensorineural  HL  with  prolongation  of  QTc  interval  in
hildren.  The  cause  of  this  association  is  unknown.11,12
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Evaluation  of  ECG  in  patients  with  hearing  loss  genotyped  fo
This  study  measured  electrocardiographic  parameters  in
patients  with  HL,  who  were  also  tested  for  genetic  muta-
tion.  Analysis  of  the  electrocardiogram  (ECG)  provided  PR
interval,  QRS  complex,  and  QTc  interval,  and  these  elec-
trocardiographic  parameters  were  compared  in  two  groups
of  patients:  one  with  HL  caused  by  mutations  in  the  GJB2
gene  and  another  with  HL  and  no  mutation  in  this  gene.  In
this  way,  it  was  possible  to  investigate  whether  there  was  a
relationship  between  connexin  26  and  connexin  30  functions
and  cardiac  electrical  activity.
Methods
The  study  population
The  study  group  consisted  of  346  consecutive  patients,  aged
21.8  ±  19.9  years  (0.16--84  years),  including  176  males  and
170  females,  with  sensorineural  HL  of  30  dB  or  more  (cal-
culated  as  the  average  hearing  threshold  at  frequencies
relevant  for  speech  --  0.5,  1,  2,  and  4  kHz)  and  on  whom
genetic  tests  were  done  to  identify  mutations  in  GJB2  and
GJB6.  The  HL  was  conﬁrmed  by  pure  tone  audiometry  or,  in
the  case  of  children  less  than  6  years  old,  Brainstem  Evoked
Response  Audiometry  (BERA).  Among  the  subjects  studied,
91  had  cochlear  implants.
Genetic  tests
DNA  was  extracted  from  the  peripheral  blood  by  a  salting-
out  procedure.13 The  typing  for  the  c.35delG  mutation  in
GJB2  gene  was  performed  by  two  independent  methods:
AS-PCR  and  PCR-RFLP,  as  described  previously.14,15 Brieﬂy,
multiplex  ampliﬁcation  of  three  GJB2  regions  (c.12-72,
c.68-198  and  c.306-464)  with  ﬂuorescent  labeled  primers
was  performed.  In  parallel,  PCR-RFLP  analysis  speciﬁc  for
c.35delG  mutation  was  conducted.  Size  of  the  fragments
generated  by  the  two  above-mentioned  protocols  was  deter-
mined  using  a  3500XL  Genetic  Analyzer  (Life  Technologies)
with  Gene  Mapper  (Life  Technologies)  software.  Samples
lacking  two  c.35delG  mutations  were  further  analyzed  by
direct  DNA  sequencing  of  the  PCR  ampliﬁed  exon  2  of
the  gene.  Sequence  analysis  was  performed  with  Vari-
ant  Reporter  v1.1  (Life  Technologies)  software.  Genotyping
of  the  c.-23+1G>A  GJB2  mutation  was  performed  using
real-time  PCR  according  to  the  manufacturer’s  instructions
(Life  Technologies),  while  the  GJB6  mutation  del  (GJB6-
D13S1830)  was  detected  using  the  method  of  del  Castillo
et  al.16 Genetic  nomenclature  is  in  line  with  recommenda-
tions  of  the  Human  Genome  Variation  Society  (HGVS).
Electrocardiographic  tests
All  346  patients  underwent  a  12  lead  Electrocardiogram
(ECG).  ECG  recording  was  performed  and  evaluated  using
the  Sentinel  Cardiology  Information  Management  System
(Reynolds  Medical).  The  durations  of  PR  interval,  QRS  com-
plex,  and  QTc  interval  were  measured  by  a  single  observer
on  a  5  times  enlarged  image  on  a  computer  monitor  with
a  cursor  accuracy  of  1  ms  (sampling  frequency  1000  Hz).  PR
interval  was  usually  measured  in  lead  II,  QRS  complex  in
u
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1  and/or  V5,  and  QT  interval  in  at  least  three  leads  of  the
ame  cycle  (usually  leads  II,  V2,  and  V5).  Heart  rate  was  cal-
ulated  from  the  RR  interval  preceding  the  cycle  of  the  QT
nterval  measured.  To  correct  QT  interval  due  to  heart  rate
i.e.,  QTc),  Bazett’s  formula  was  used  for  rates  between  50
nd  120  bpm;  for  faster  or  slower  rates  Hodges’  formula  was
sed.  In  order  to  calculate  average  QTc,  patients  with  QRS
omplexes  ≥120  ms  were  excluded.  A  QTc  interval  above
60  ms  in  women,  450  ms  in  men,  and  440  ms  in  children
nder  14  years  of  age,  was  diagnosed  as  prolonged.
The  study  population  was  divided  into  three  groups  based
n  reference  values  of  QTc  for  children,  women,  and  men,17
iving  147  children  <14  years  (42.4%  of  patients),  100  women
14  years  (28.9%),  and  99  men  ≥14  years  (28.6%).  The  group
f  children  included  70  (47%)  girls.
tatistical  analysis
tatistical  analysis  of  each  of  the  three  groups  involved  a
ruskal--Wallis  test  and  a  Wilcoxon  two-sample  test.
ther
he  study  was  approved  by  the  Bioethics  Committee,
pproval  number  KB/05/2009.  The  study  was  done  in  accor-
ance  with  the  principles  of  the  Declaration  of  Helsinki.  All
atients  or  their  guardians  gave  written  consent  to  partici-
ate.
esults
haracteristics  of  the  study  population  and  genetic
tudies
utations  in  GJB2  were  identiﬁed  in  112  (32%)  patients  with
L.  No  mutations  were  detected  in  the  GJB2  and  GJB6  genes
nalyzed  in  the  other  234  (68%).
The  mean  age  of  children  with  a GJB2  mutation  and
hildren  without  GJB2  mutation  was  similar  (6.0  ±  4.6
s.  5.8  ±  4.5  years,  p  =  0.86).  The  mean  age  of  adults
n  both  groups  (with  and  without  GJB2  mutation)  was
lso  similar  (35.1  ±  17.6  vs.  30.5  ±  16.5  years,  p  =  0.17  for
omen;  31.6  ±  18.9  and  30.3  ±  17.5  years,  p  =  0.99  for  men)
Table  1).
The  homozygous  genotype  c.[35delG];[(35delG)]  in  the
JB2  gene  was  detected  in  72  (20.8%)  subjects.  In  40  (11.8%)
ndividuals,  heterozygous  GJB2  genotypes  were  identiﬁed:
.[35delG];[=]  (n  =  15),  c.[35delG(;)313  326del]  (n  =  5),
.[35delG(;)-23+1G>A]  (n  =  4),  c.[313  326del];[=]  (n  =  2),
.[35delG(;)551G>C]  (n  =  2),  c.[35delG(;)95G>A]  (n  =  2),
nd  a  compound  GJB2  and  GJB6  heterozygous  genotype
GJB2:c.35delG];[GJB6:del(GJB6-D13S1830)]  (n  =  2).  The
ollowing  GJB2  heterozygous  genotypes  occurred  in  individ-
al  cases:  c.[35delG(;)269T>C],  c.[148G>A];[=],  c.[79G>A;
41G>A;  269T>C],  c.[101T>C];[=],  c.[35delG(;)235delC],
.[35delG(;)358  360delGAG],  c.[35delG(;)139G>T],
.[334  335delAA];[=]  (Table  2).
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Table  1  Characteristics  of  the  group  of  patients  diagnosed  with  mutations  in  gene  GJB2  (genotype  homozygous  and  heterozygous
together) and  the  group  of  patients  without  any  mutation  in  the  gene.
Group  of  patients  with
GJB2  mutation
Group  of  patients
without  GJB2  mutation
Number  of  patients  --  total  112  234
Number of  children  <14  years  (%  of  group)  52  (46.4%)  95  (40.6%)
Number of  women  ≥14  years 34  66
Number of  men  ≥14  years 26  73
Mean age  (years)  in  performance  of  ECG 20.8 20.2
Number  (%)  of  patients  in  the  group  after  the  implantation  of  a  screw 28  (25%) 62  (26%)
Number (%)  of  patients  with  a  signiﬁcant  HL  55  (48%)  103  (44%)
Number (%)  of  patients  with  an  average  degree  of  HL  6  (5%)  30  (8%)
Number (%)  of  patients  with  congenital  HL  (n  =  200)  62  (55%)  138  (59%)
Table  2  Types  of  genotype  and  their  distribution  in  the  study  population.
Genotype  GJB2 Children  Adults
Girls  Boys  Women  Men
c.[35delG];[(35delG)]  15  19  21  17
[GJB2:c.35delG];[GJB6:del(GJB6-D13S1830)]  1  1
c.[35delG(;)313  326del]  2  1  1  1
c.[35delG(;)-23+1G>A]  1  2  1
c.[35delG];[=]  4  3  6  2
c.[35delG(;)269T>C]  1
c.[35delG(;)235delC]  1
c.[35delG(;)358  360delGAG]  1
c.[35delG(;)551G>C]  1  1
c.[35delG(;)95G>A]  1  1
c.[35delG(;)139G>T]  1
c.[148G>A];[=]  1
c.[313 326del];[=] 1  1
c.[79G>A; 341G>A;  269T>C] 1
c.[334 335delAA];[=] 1
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lectrocardiographic  ﬁndings
he  next  phase  of  the  study  was  to  compare  electrocardio-
raphic  parameters  in  the  study  population.  The  measured
arameters  were  compared  between  two  groups:  the  group
f  patients  with  a  mutation  in  gene  GJB2  (both  homozy-
otes  and  heterozygotes)  and  the  group  of  patients  with
o  mutation  in  the  gene.  No  signiﬁcant  differences  were
p
t
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Table  3  Findings  of  PR  interval  in  the  ECG  study  population.
Groupa Patients  with  a  mutation  in  GJB2  
Mean
PR  ±  SD  (ms)
Lowest
value  (ms)
Highest
value  (ms
Children  (n  =  44/78)  126.3  ±  19.6  103  186  
Women (n  =  33/57)  148.7  ±  21.0  111  192  
Men (n  =  23/57)  155.0  ±  16.6  114  176  
a Numbers in brackets indicate the number of patients with/without 1
ound  for  any  measured  parameter  in  any  of  the  groups  stud-
ed.  Table  3  presents  inter-group  differences  in  PR  interval;
able  4  presents  inter-group  differences  in  QRS  complex;  and
able  5  presents  inter-group  differences  in  QTc  interval.In  addition,  we  compared  parameters  in  patients  with
rofound  HL  caused  by  a  GJB2  mutation  homozygous  geno-
ype  c.[35delG];[(35delG)]  and  in  those  with  a  heterozy-
ous  genotype  [GJB2:c.35delG];[GJB6:del(GJB6-D13S1830)]
Patients  without  any  mutation  in  GJB2 p  (NS)
)
Mean
PR  ±  SD  (ms)
Lowest
value  (ms)
Highest
value  (ms)
127  ±  19.7  100  177  0.74
143.8  ±  22.8  111  264  0.11
153.6  ±  30.1  116  265  0.12
GJB2 mutation.
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Table  4  Findings  of  QRS  complex  in  the  ECG  study  population.
Group Patients  with  a  mutation  in  GJB2  Patients  without  any  mutation  in  GJB2 p  (NS)
Mean
QRS  ±  SD  (ms)
Lowest
value  (ms)
Highest
value  (ms)
Mean
QRS  ±  SD  (ms)
Lowest
value  (ms)
Highest
value  (ms)
Children  (n  =  49/89)a 80.7  ±  9.5  65  99  79.4  ±  11.6  61  114  0.32
Women (n  =  33/59)  94.8  ±  7.6  80  110  92.9  ±  9.6  65  118  0.31
Men (n  =  23/59)  99.9  ±  9.9  85  119  101.1  ±  15.4  65  156  0.98
a Numbers in brackets indicate the number of patients with/without GJB2 mutation.
Table  5  Findings  of  QTc  interval  in  the  ECG  study  population.
Groupa Patients  with  a  mutation  in  GJB2  Patients  without  any  mutation  in  GJB2 p  (NS)
Mean
QTc  ±  SD  (ms)
Lowest
value  (ms)
Highest
value  (ms)
Mean
QTc  ±  SD  (ms)
Lowest
value  (ms)
Highest
value  (ms)
Children  (52/94)  419.7  ±  23.5  366  479  419.8  ±  24.8  371  483  0.91
Women (34/64)  416.8  ±  20.6  371  456  424.9  ±  22.8  370  467  0.08
hout 
r
l
i
l
i
t
v
c
h
aMen (26/61)  414.9  ±  29.9  366  485  
a Numbers in brackets indicate the number of patients with/wit
versus  all  other  patients  with  other  types  of  HL.  The  analysis
revealed  no  signiﬁcant  differences  (Table  6).
Finally,  we  analyzed  the  incidence  of  ECG  abnormali-
ties  in  the  group  of  patients  with  a  mutation  in  GJB2  and
those  without  any  mutation  in  this  gene.  The  abnormali-
ties  in  the  group  of  patients  with  a  mutation  were:  atrial
rhythm  (2  patients),  sinus  bradycardia  (n  =  12),  short  time
atrioventricular  conduction  (n  =  3),  left  anterior  fascicular
block  (n  =  1),  a  QTc  interval  above  the  norm  for  age  and  sex
(n  =  10),  and  signs  of  myocardial  inferolateral  wall  necro-
sis  associated  with  prolonged  QTc  (n  =  1).  In  the  group  of
patients  without  any  mutation,  abnormalities  were:  sinus
bradycardia  (n  = 25),  atrial  rhythm  (n  =  3),  wandering  atrial
pacemaker  (n  =  1),  short  time  atrioventricular  conduction
(n  =  2),  ﬁrst  degree  atrioventricular  block  (n  =  5),  incomplete
4
a
w
(
Table  6  Findings  of  PR  interval,  QRS  complex,  and  QTc  interva
c.[35delG];[(35delG)]  and  heterozygous  genotype  [GJB2:c.35delG];
other heterozygous  genotype  and  without  any  mutation  in  GJB2).
Children  (n  =  31/90)a
Mean  PR  ±  SD  (ms)  in  group  A  122.55  ±  18.51  
Mean PR  ±  SD  (ms)  in  group  B  128.02  ±  25.38  
p 0.0633  
Children  (n  =  33/104)  
Mean  QRS  ±  SD  (ms)  in  group  A  79.81  ±  9.81  
Mean QRS  ±  SD  (ms)  in  group  B  79.87  ±  13.2  
p 0.4528  
Children  (n  =  36/111)  
Mean  QTc  ±  SD  (ms)  in  group  A  418.33  ±  20.4  
Mean QTc  ±  SD  (ms)  in  group  B  420.5  ±  24.16  
p 0.4462  
a Numbers in brackets indicate the number of patients in group A/B, 412.4  ±  25.7  362  476  0.86
GJB2 mutation.
ight  bundle  branch  block  (n  =  1),  left  anterior  fascicu-
ar  block  (n  =  1),  complete  bundle  branch  block  (n  =  7),
ntraventricular  conduction  disturbances  (n  =  3),  signs  of
eft  ventricular  hypertrophy  (n  =  3),  signs  of  myocardial
schemia  (n  =  2),  and  prolonged  QTc  (n  =  23).  In  one  boy,
here  was  supraventricular  rhythm  with  a  prolonged  atrio-
entricular  conduction  time,  nonspeciﬁc  intraventricular
onduction  disturbances,  and  signs  of  right  ventricular
ypertrophy.
In  the  group  of  patients  with  a  GJB2  mutation
nd  prolonged  QTc  (n  =  10),  the  mean  QTc  interval  was
63.2  ±  15.6  ms,  whereas  in  patients  with  prolonged  QTc
nd  without  any  mutation  (n  =  23),  the  mean  QTc  interval
as  460.3  ±  12.8  ms.  This  difference  was  also  not  signiﬁcant
p  =  0.69).
l  in  2  groups.  Group  A,  patients  with  homozygous  genotype
[GJB6:del(GJB6-D13S1830)];  group  B,  all  other  patients  (with
Women  (n  =  20/70)  Men  (n  =  15/58)
144.1  ±  22.98  153.8  ±  15.07
146.3  ±  25.74  154.05  ±  25.55
0.3934  0.1174
Women  (n  =  20/72)  Men  (n  =  15/60)
94.05  ±  7.91  98.6  ±  10.18
93.24  ±  13.17  101.27  ±  13.88
0.4124  0.4577
Women  (n  =  20/79)  Men  (n  =  17/74)
417.3  ±  18.45  412.41  ±  32.65
423.74  ±  24.07  414.47  ±  24.16
0.0908  0.4594
respectively.
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iscussion
ur  study  acquired  ECGs  from  346  patients  with  HL  who  were
ested  for  mutations  in  GJB2  and  GJB6  genes.  There  is  a
eneral  lack  of  data  on  detailed  ECG  parameters  in  simi-
arly  large  populations.  There  have  been  reports  of  normal
CGs  performed  on  11  patients  aged  9--20  years  in  5  fami-
ies  with  HL  associated  with  GJB2  mutations.18 In  addition,
nother  study19 described  270  children  with  sensorineural
L  of  which  143  underwent  an  ECG:  abnormalities  were
etected  in  10  (7%),  3  had  prolonged  QT  interval  (1  had  mul-
iple  atrial  and  ventricular  septal  defects  and  2  were  both
iagnosed  with  Jervell  and  Lange--Nielsen  syndrome),  and
ther  reported  abnormalities  included  sinus  bradycardia,
ight  bundle  branch  block,  and  left  ventricular  hypertrophy.
f  220  children  in  the  study  group,  33  (15%)  had  mutations
n  both  alleles  of  the  GJB2  gene.
Our  study  is  the  ﬁrst  to  our  knowledge  to  describe  ECG
arameters  such  as  PR  interval  and  QRS  complex  in  a  large
roup  of  patients  with  HL.  GJB2  gene  mutations  cause  HL
n  20--60%  of  Caucasian  children.  The  prevalence  of  GJB2
utations  in  the  European  population  is  highest  in  Mediter-
anean  countries  and  lowest  in  the  north  of  the  continent.
t  is  estimated  that  the  c.35delG  mutation  is  carried  by
--3%  of  the  European  population.20,21 The  most  common
JB2  genotype  occurring  in  European  patients  with  HL  is
he  homozygous  genotype  c.[35delG];[(35delG)].20,21 In  our
tudy  group  of  patients  with  HL,  this  genotype  was  also  the
ost  common.  Furthermore,  we  have  shown  that  among
he  population  studied  there  were  also  other  mutations,
lthough  they  were  rare.  One  rare  mutation,  the  c.167delT
eported  by  Dong  et  al.22 should  be  noted,  however,  as  this
utation  is  uncommon  in  Europe  generally  but  much  more
requent  in  Ashkenazi  Jews.23 In  contrast,  the  most  common
utation  in  Japanese  is  c.235delC,  where  its  prevalence  is
--2.1%.24
In  addition  to  connexin  26,  a  similar  biological  role  in
he  inner  ear  is  also  contributed  by  connexin  30,  encoded
y  the  GJB6  gene,  whose  locus  is  located  in  the  imme-
iate  vicinity  of  the  GJB2  gene  on  chromosome  13.25,26
eletion  of  342  kb  encompassing  the  GJB6  gene  has  been
escribed,  particularly  in  Spanish  patients.  Further  stud-
es  have  shown  that  the  phenotypic  effects  of  mutations
n  both  genes  are  identical,  and  a  compound  heterozy-
ous  genotype  [GJB2:c.35delG];[GJB6:del(GJB6-D13S1830)]
s  characterized  by  hearing  loss.16
Our  assessment  of  electrocardiographic  parameters  in
atients  with  HL  caused  by  GJB2  mutation  has  shown  that
trioventricular  conduction  (deﬁned  by  PR  interval),  intra-
entricular  conduction  time  (deﬁned  by  QRS  duration),  and
he  QTc  interval  did  not  differ  signiﬁcantly  in  comparison
o  patients  with  HL  who  did  not  have  any  mutations  in  this
ene.
imitations  of  the  study
ur  study  did  contain  some  limitations.  Different  phenotypic
xpressions  are  the  result  of  various  GJB2  mutations.  Since
he  described  GJB2  gene  mutations  that  result  in  HL  are
ecessive,  we  compared  parameters  from  a  group  of  patients
ith  a  homozygous  c.[35delG];[(35delG)]  genotype  and  a
1 PRESS
Sanecka  A  et  al.
eterozygous  [GJB2:c.35delG];[GJB6:del(GJB6-D13S1830)]
enotype  with  all  other  patients.  The  results  of  such
n  analysis  are  limited  by  the  small  number  of  peo-
le  with  a  homozygous  c.[35delG];[(35delG)]  genotype,
nd  there  were  only  2  children  with  heterozygous
GJB2:c.35delG];[GJB6:del(GJB6-D13S1830)]  genotype  giv-
ng  the  phenotypic  effect  of  deafness.
In  the  study  group,  the  presence  of  heart  defects  has
ot  been  ruled  out  by  a reliable  test  (e.g.  echocardiog-
aphy),  and  neither  has  the  effect  of  certain  medications
hich  might  have  inﬂuenced  electrocardiographic  parame-
ers.  The  study  group  was  selected  by  screening  of  people
ith  HL  who  did  not  report  symptoms  of  heart  disease  or
id  not  take  drugs,  producing  a group  of  apparently  healthy
eople  who  had  HL.
onclusion
n  patients  with  HL,  no  association  was  found  between  ECG
arameters  and  the  presence  of  GJB2  mutations  encoding
onnexin  26.
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